MoneyWorks4Me

Smruthi Organics - Quaterly Results

05 Aug 2023 Evaluate
A fair growth of 20.08% in the revenue at Rs. 349.12 millions was reported in the June 2023 quarter as compared to Rs. 290.73 millions during year-ago period.The Total revenue for the quarter ended June 2023 of  Rs. 22.93  millions  grew by 654.28% from Rs. 3.04 millions.Operating profit for the quarter ended June 2023 rose to 46.29 millions as compared to 17.47 millions of corresponding quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 349.12 290.73 20.08 349.12 290.73 20.08 1410.41 1333.72 5.75
Other Income 0.11 0.31 -64.52 0.11 0.31 -64.52 1.07 5.83 -81.65
PBIDT 46.29 17.47 164.97 46.29 17.47 164.97 98.87 190.12 -48.00
Interest 3.25 1.19 173.11 3.25 1.19 173.11 8.23 9.84 -16.36
PBDT 43.04 16.28 164.37 43.04 16.28 164.37 90.64 180.28 -49.72
Depreciation 12.39 11.15 11.12 12.39 11.15 11.12 45.72 42.56 7.42
PBT 30.65 5.13 497.47 30.65 5.13 497.47 44.92 137.72 -67.38
TAX 7.72 2.09 269.38 7.72 2.09 269.38 3.63 33.90 -89.29
Deferred Tax -1.13 -0.13 769.23 -1.13 -0.13 769.23 -10.97 -1.70 545.29
PAT 22.93 3.04 654.28 22.93 3.04 654.28 41.29 103.82 -60.23
Equity 114.46 114.46 0.00 114.46 114.46 0.00 114.46 114.46 0.00
PBIDTM(%) 13.26 6.01 120.65 13.26 6.01 120.65 7.01 14.25 -50.82
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..